- Record: found
- Abstract: not found
- Article: not found
Phase II study of CC-5013 (revlimid) and rituximab in Waldenstrom’s macroglobulinemia: preliminary safety and efficacy results
2005
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.